You have 9 free searches left this month | to do more
Showing 1 - 25 of
>10,000 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
F
Not yet recruiting
  • Recurrent Chronic Lymphocytic Leukemia
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-03-31
Mar 31, 2022
S
Terminated
  • Chronic Lymphocytic Leukemia
  • +3 more
  • TP-0903
  • TP-0903 and ibrutinib combination therapy
  • Phoenix, Arizona
  • +5 more
2022-04-04
Apr 4, 2022
J
Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma
  • Boston, Massachusetts
  • +2 more
2022-03-16
Mar 16, 2022
M
Completed
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2019-09-24
Sep 24, 2019
U
Active, not recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma (SLL)
  • Rochester, New York
    University of Rochester
2022-02-07
Feb 7, 2022
M
Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
2022-04-07
Apr 7, 2022
X
Active, not recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Oncoquest-CLL vaccine
  • Chicago, Illinois
    Robert H. Lurie Comprehensive Cancer Center at Northwestern Univ
2021-04-07
Apr 7, 2021
U
Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • La Jolla, California
    UCSD Moores Cancer Center
2021-04-08
Apr 8, 2021
C
Enrolling by invitation
  • Relapsed/Refractory B-cell Lymphomas
  • +8 more
  • CLBR001 and SWI019
  • Duarte, California
  • +7 more
2021-11-30
Nov 30, 2021
D
Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Boston, Massachusetts
  • +2 more
2021-08-09
Aug 9, 2021
H
Suspended
  • Chronic Lymphocytic Leukemia
  • Tampa, Florida
    H. Lee Moffitt Cancer Center & Research Institute
2022-02-07
Feb 7, 2022
K
Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Refractory Chronic Lymphocytic Leukemia
  • Bcl-2 Inhibitor GDC-0199
  • +5 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
2021-10-29
Oct 29, 2021
U
Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • CLL
  • La Jolla, California
    University of California, San Diego
2021-09-02
Sep 2, 2021
N
Terminated
  • Small Lymphocytic Leukemia (SLL)
  • Chronic Lymphocytic Leukemia (CLL)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-02-15
Feb 15, 2022
N
Active, not recruiting
  • Safety and Tolerability
  • +3 more
  • Zoster Vaccine Recombinant, Adjuvanted
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-01-10
Jan 10, 2022
N
Completed
  • Hepatitis
  • Safety and Tolerability
  • HEPLISAV-B
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-01-13
Jan 13, 2022
D
Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
2021-09-08
Sep 8, 2021
U
Active, not recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Waldenstrom Macroglobulinemia (WM)
  • Shingrix vaccine
  • Rochester, New York
    University of Rochester
2022-02-07
Feb 7, 2022
M
Recruiting
  • Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
2021-02-08
Feb 8, 2021
A
Recruiting
  • Chronic Lymphocytic Leukemia
    • Athens, Attiki, Greece
    • +20 more
    2022-03-21
    Mar 21, 2022
    U
    Recruiting
    • Chronic Lymphocytic Leukemia
    • Non-hodgkin Lymphoma
    • huCART19-IL18
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    2021-10-18
    Oct 18, 2021
    M
    Recruiting
    • Chronic Lymphocytic Leukemia (CLL)
    • Small Lymphocytic Leukemia (SLL)
    • Boston, Massachusetts
    • +6 more
    2022-03-14
    Mar 14, 2022